Overexpression of annexin II has been associated with progression and metastasis in hepatocellular carcinoma, pancreatic cancer, colorectal cancer, lung cancer, breast cancer and renal cell carcinoma [9,11,25,26]. Here, ANXA2 is linked to hepatocellular carcinoma.